Divastin-E Tablet 20 mg+10 mg is a combination lipid-lowering medication containing Atorvastatin 20 mg and Ezetimibe 10 mg, formulated to provide potent control of high cholesterol and mixed dyslipidemia. By combining a statin with a cholesterol absorption inhibitor, Divastin-E delivers a dual mechanism of action to reduce LDL cholesterol, triglycerides, and overall cardiovascular risk.

Atorvastatin, a member of the statin class, works by inhibiting HMG-CoA reductase, the enzyme responsible for cholesterol production in the liver. This reduces low-density lipoprotein (LDL) cholesterol, lowers triglycerides, and modestly increases high-density lipoprotein (HDL) cholesterol, helping to prevent atherosclerosis and related cardiovascular complications.

Ezetimibe complements this effect by selectively blocking the absorption of dietary and biliary cholesterol in the small intestine. By targeting both cholesterol synthesis and absorption, Divastin-E provides a comprehensive approach to lipid management, making it suitable for patients who do not achieve adequate control with statin monotherapy or require intensified cholesterol-lowering therapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Divastin-E Tablet 20 mg+10 mg is indicated for:

• Primary hypercholesterolemia: To lower elevated total cholesterol, LDL cholesterol, and triglycerides

• Mixed dyslipidemia: Management of patients with combined lipid abnormalities

• Patients inadequately controlled on statin therapy alone: To achieve LDL cholesterol targets

• Cardiovascular risk reduction: In adults at high risk of heart attack, stroke, or coronary artery disease

• Adjunct to dietary and lifestyle interventions, including a low-fat diet, regular physical activity, and weight control

This combination is particularly beneficial for patients who require intensive lipid-lowering therapy while minimizing the statin dose to reduce potential side effects.

Dosage and Administration

• Adults: Usually, one tablet orally once daily, with or without food, as prescribed by a physician.

• It is recommended to take Divastin-E at the same time each day to maintain consistent blood levels.

• Patients should continue heart-healthy lifestyle measures to enhance the drug’s effectiveness.

Dose adjustments may be necessary in patients with hepatic or renal impairment or other medical conditions, under physician supervision.

Precautions

• Contraindicated in patients with active liver disease, unexplained persistent elevation of liver enzymes, or hypersensitivity to Atorvastatin, Ezetimibe, or any tablet components.

• Use cautiously in patients with liver or kidney impairment, history of muscle disorders, or heavy alcohol use.

• May interact with other medications such as certain antifungals, antibiotics, or immunosuppressants; consult a healthcare professional before combining therapies.

• Pregnant or breastfeeding women should avoid use, as Atorvastatin may harm the fetus or infant.

• Regular monitoring of liver function, kidney function, and lipid profile is recommended during therapy.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Divastin-E Tablet is generally well tolerated. Common side effects include:

• Gastrointestinal discomfort: nausea, constipation, abdominal pain

• Headache or mild fatigue

• Muscle aches, cramps, or weakness

Rare but serious side effects may include:

• Myopathy or rhabdomyolysis (severe muscle breakdown)

• Liver enzyme elevation or liver dysfunction

• Allergic reactions such as rash, swelling, or itching

Patients should seek immediate medical attention if they experience unexplained muscle pain, dark urine, persistent fatigue, or jaundice.

Storage

Store below 30°C in a cool, dry place, protected from light and moisture. Keep out of reach of children.

Divastin-E Tablet 20 mg+10 mg provides effective dual-action cholesterol management, combining Atorvastatin’s liver-targeted effects with Ezetimibe’s intestinal cholesterol absorption inhibition. This combination supports optimal lipid control, cardiovascular risk reduction, and long-term heart health under medical supervision.